Today, the Eclipse has become an Icon, so let's explore just how it got there. The Eclipse would not have existed without one of the most overlooked partnerships of the 1980s and 1990s: Diamond-Star ...

Gilead Sciences' TROP2-targeting drug Trodelvy is already used as a third-line treatment for PD-L1-positive triple-negative breast cancer (TNBC), but could be heading for use in previously untreated ...